fulvestrant
(fulvestrant)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Usage: Fulvestrant injection is indicated for the treatment of hormone receptor-positive, HER2-negative advanced breast cancer in postmenopausal women, either as monotherapy for those not previously treated with endocrine therapy or as part of combination therapy with ribociclib, palbociclib, or abemaciclib after disease progression.